Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|October 16, 2016
Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumorsMayuko Furuta, Masaki Ueno, Akihiro Fujimoto, et al.
Nature Communications|June 13, 2015
TCF12 is mutated in anaplastic oligodendrogliomaKarim Labreche, Iva Simeonova, Aurélie Kamoun, et al.
Experimental Hematology & Oncology|August 23, 2025
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibitionHayley M Sabol, Aric Anloague, Japneet Kaur, et al.
Cell Reports|September 14, 2017
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer PolymorphismNi Li, David C Johnson, Niels Weinhold, et al.
Nature Communications|April 24, 2015
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myelomaBrian A Walker, Christopher P Wardell, Alex Murison, et al.
Cells|December 24, 2021
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for GlioblastomaMegan R Reed, A Geoffrey Lyle, Annick De Loose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2016
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in MyelomaCharlotte Pawlyn, Martin F Kaiser, Christoph Heuck, et al.
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2020
<i>BRAF</i> and <i>DIS3</i> Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple MyelomaEileen M Boyle, Cody Ashby, Ruslana G Tytarenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A Walker, Eileen M Boyle, Christopher P Wardell, et al.
Pageof 5